Global Biologics Consulting Services Market is expected to witness a decent CAGR of >15%
While small molecules are either made synthetically or purified from plants , biologics are medicines made from living cells. Although small molecules comprise >90% of drugs on the market, pharma and biotech companies are gradually shifting their focus to manufacturing and developing highly profitable biologics drugs. The Complex Nature of Biologics and its Increasing Importance Drives the Market Demand Compared to small molecules, biologics are large, highly complex, heterogeneous molecules, more expensive, sensitive to external conditions, need to go through challenging manufacturing processes and have stringent regulatory requirements, thus requiring a greater level of expertise. With the increasingly complex and rapidly evolving biopharma industry, companies are looking for consultancies that are able to provide significant regulatory leadership, product development consulting, and expertise in all stages from early-stage discovery to commercialization. Moreover, the incre...